169 related articles for article (PubMed ID: 12008091)
1. Angiogenesis in multiple myeloma.
Sezer O; Niemöller K; Jakob C; Heider U
Leuk Res; 2002 Jul; 26(7):701-2. PubMed ID: 12008091
[No Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor and its receptors in multiple myeloma.
Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D
Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
[TBL] [Abstract][Full Text] [Related]
3. Tumoral vascularity as a prognostic factor in cancer.
Weidner N; Folkman J
Important Adv Oncol; 1996; ():167-90. PubMed ID: 8791135
[No Abstract] [Full Text] [Related]
4. Can mosaic tumor vessels facilitate molecular diagnosis of cancer?
Folkman J
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):398-400. PubMed ID: 11209044
[No Abstract] [Full Text] [Related]
5. [Tumor angiogenesis].
Ono M; Kuwano M
Seikagaku; 1998 Sep; 70(9):1159-70. PubMed ID: 9796411
[No Abstract] [Full Text] [Related]
6. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
Nefedova Y; Landowski TH; Dalton WS
Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and angiogenic mediators in haematological malignancies.
Mangi MH; Newland AC
Br J Haematol; 2000 Oct; 111(1):43-51. PubMed ID: 11091181
[No Abstract] [Full Text] [Related]
8. Bone marrow angiogenesis in multiple myeloma: closing in on the loop.
Molina JR; Rajkumar SV
Haematologica; 2003 Feb; 88(2):122-4. PubMed ID: 12604399
[No Abstract] [Full Text] [Related]
9. Vascular endothelial growth factor: molecular and biological aspects.
Ferrara N
Curr Top Microbiol Immunol; 1999; 237():1-30. PubMed ID: 9893343
[No Abstract] [Full Text] [Related]
10. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
11. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
[No Abstract] [Full Text] [Related]
12. Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 4. Molecular pathogenesis of lung cancer and its molecular targeted therapy.
Sone S; Shinohara T; Nishioka Y; Yano S
Intern Med; 2001 Feb; 40(2):167-70. PubMed ID: 11300157
[No Abstract] [Full Text] [Related]
13. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis.
Giuliani N; Colla S; Lazzaretti M; Sala R; Roti G; Mancini C; Bonomini S; Lunghi P; Hojden M; Genestreti G; Svaldi M; Coser P; Fattori PP; Sammarelli G; Gazzola GC; Bataille R; Almici C; Caramatti C; Mangoni L; Rizzoli V
Blood; 2003 Jul; 102(2):638-45. PubMed ID: 12649156
[TBL] [Abstract][Full Text] [Related]
14. [Study on angiogenesis of multiple myeloma in vitro].
Chen WM; Wu Y; Zhu JZ; Soria J; Mirshahi M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):310-4. PubMed ID: 12513764
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and antiangiogenic therapy.
Sledge GW; Miller KD
Curr Probl Cancer; 2002; 26(1):1-60. PubMed ID: 11961506
[No Abstract] [Full Text] [Related]
16. Angiogenesis and angiogenesis inhibition: an overview.
Folkman J
EXS; 1997; 79():1-8. PubMed ID: 9002217
[No Abstract] [Full Text] [Related]
17. The regulation of blood vessel growth by vascular endothelial growth factor.
Ferrara N; Heinsohn H; Walder CE; Bunting S; Thomas GR
Ann N Y Acad Sci; 1995 Mar; 752():246-56. PubMed ID: 7538737
[No Abstract] [Full Text] [Related]
18. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
Gupta D; Treon SP; Shima Y; Hideshima T; Podar K; Tai YT; Lin B; Lentzsch S; Davies FE; Chauhan D; Schlossman RL; Richardson P; Ralph P; Wu L; Payvandi F; Muller G; Stirling DI; Anderson KC
Leukemia; 2001 Dec; 15(12):1950-61. PubMed ID: 11753617
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor as a target for antiangiogenic therapy.
Gordon MS
J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
[No Abstract] [Full Text] [Related]
20. Inhibitors of the vascular endothelial growth factor receptor.
Rosen LS
Hematol Oncol Clin North Am; 2002 Oct; 16(5):1173-87. PubMed ID: 12512388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
